Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Hypofractionated Radiochemotherapy for Women With Metastatic or Bulky Uterine Cervix Cancer

NCT06331468 is registered in ClinicalTrials.gov with Denise Fabian as lead sponsor.

NCT NCT06331468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06331468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Hypofractionated Radiochemotherapy for Women With Metastatic or Bulky Uterine Cervix Cancer
Lead sponsor
Denise Fabian
Phase
Phase 2
Overall status
Recruiting
Start date
June 26, 2025
Completion date
July 1, 2030
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uterine cervix cancer